Table 1.
Characteristic | Value (Mean ± Standard Deviation/Number of Patients [%]) |
---|---|
Male sex (n) | 22/30 (73.3) |
Age (y) | 62.2 ± 11.5 |
Weight (kg) | 88.9 ± 18.9 |
Procedure (n) | |
CABG | 10 (33.3) |
Valve repair or replacement | 10 (33.3) |
CABG/valve repair or replacement | 3 (10.0) |
VAD | 3 (10.0) |
Other | 4 (13.3) |
CPB time (min) | 124.1 ± 60.1 |
Cross-clamp time (min) | 76.0 ± 43.7 |
Preoperative medications (n) | |
Aspirin | 20 (66.6) |
Heparin | 14 (46.6) |
V-K antagonists | 6 (20) |
P2Y12 antagonists | 2 (6.6) |
Direct thrombin inhibitors | 0 (0) |
FXa inhibitors | 1 (0.3) |
Volume of cell saver administered (mL) | 1095.2 ± 921.8 |
Abbreviations: CAGB, coronary artery bypass grafting; CPB, cardiopulmonary bypass; FXa, Factor Xa; VAD, ventricular assist device; V-K, vitamin K.